GOTTLIEB, A. B.; STROBER, B.; THA?I, D.; GORDON, K.; KUNDU, S.; KISA, R.; WEI, L.; BANERJEE, S.; MEROLA, J. BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis as Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s29, 2020. DOI: 10.25251/skin.4.supp.29. Disponível em: https://www.jofskin.org/index.php/skin/article/view/978. Acesso em: 12 aug. 2022.